Beth Rizzardo
Framework by Dr. Dean Regier and Colleagues Resonates in International Contexts
A European panel of experts has highlighted the life-cycle assessment framework developed by Dr. Regier, Associate Director of the ATM, as the way forward to address timely evidence-informed access to precision oncology products. External stakeholders sharing this Canadian-based work as a thought-provoking strategy for international audiences is an indication of its applicability and relevance on a global level.
ATM Members Awarded in CIHR Project Grant: Spring 2024 Competition
The Academy of Translational Medicine celebrates 3 of its Members for their successful applications in the Canadian Institutes of Health Research (CIHR) Project Grant: Spring 2024 competition. The ATM looks forward to the outcomes of these important research initiatives funded by this cycle, and asks that you join us in congratulating Dr. Evgin, Dr. Karim, and Dr. Abdelrahman for their achievement!
What to Watch: TEDx Talk by ATM Member Dr. Shahriari
When you are in need of a dose of inspiration, watch this 12 minute TEDx Talk thet ATM Member Dr. Dena Shahriari gave in 2020, titled “Transcending Disability…Toward a Cure for Spinal Cord Injury.”
Medventions Toronto Innovation Day Announces 2024 Theme: Image-guided Therapy, Digital Health, and AI in Medicine
Medventions Toronto Innovation Day is a dynamic event showcasing groundbreaking advancements in healthcare technology and key insights in medtech entrepreneurship. Held annually, this forum brings together leading innovators, healthcare professionals, investors, and industry experts to explore the latest innovations aimed at transforming patient care.
Good Read: Bridging the Gap with Katelynn Boerner
On your next coffee break, we recommend reading this interview by Women in Neuroscience UK with Dr. Kateylynn Boerner. Dr. Boerner recently joined the ATM as a Member, and in the interview she shared her experience in working with gender diverse and neurodiverse young people with chronic pain and her opinions on the importance of creating more inclusive research practices.
Registration Open: Therapeutics Initiative – Bringing Best Evidence to Clinicians
The conference will be held on Friday 18 October and Saturday 19 October. Keynote presentations will be delivered by internationally renowned experts, Dr. Derelie (aka Dee) Mangin (Professor, McMaster University) and Dr. John Mandrola (Cardiac Electrophysiologist, Baptist Health). In addition, a diverse lineup of both new and veteran faculty members from the Therapeutics Initiative will present on various relevant topics.
Explore the BC MS Cell Therapies Translational Research Network on MedNet
The new MS Research Network section on MedNet is a fantastic source of information as part of a longer-term plan to grow awareness of the MS Research Network among the UBC Faculty of Medicine community. There are currently funding opportunities which may be of relevance for those involved in translational medicine.
Promising research regarding cancer-causing proteins illuminates the benefits of collaborative science for propelling research findings towards diagnostic and therapeutic opportunities
As a leader in translational medicine, Dr. Sorensen advocates for others to work collaboratively in the pursuit of collective excellence. In a breakthrough article announced by BC Cancer Research, Dr. Sorensen worked with esteemed researchers both in Canada and internationally to unravel one of the many elaborate mechanisms used by cancerous cells to propagate disease, including those from the Vancouver Prostate Centre, the University of Toronto, and the Technical University of Munich (where Dr. Sorensen is also an Ambassador).
Dr. Dena Shahriari Receives VCHRI Innovation and Translational Research Awards
Please join us in congratulating Dr. Dena Shahriari, who is the recipient of a VCHRI 2024 Innovation and Translational Research Award. These awards support investigators who are putting new knowledge into practice, implementing research outcomes and turning discoveries into commercial opportunities.
Now Open: 2024 Precision Health Catalyst Grant Competition
The catalyst grants are intended to enable precision health pilot research projects and to facilitate inter-faculty and cross-institute collaboration. Up to four grants will be awarded in the 2024 round, at a maximum of $50,000 each. The grants will support a project led by two investigators, where the primary applicant must be an early career researcher. Through this grant competition, Precision Health aims to encourage new collaborations and support early career researchers and teams.